ROBOTICS & AUTOMATION
ICON Raises $200M to Put 3D-Printing Robots on Construction Sites
ICON, the Austin robotic-construction company, raised a $200M Series D co-led by Baillie Gifford and BlackRock — part of a ~$510M week for robotics startups. The capital funds commercial production of Titan, its multi-story 3D-printing system that ICON says cuts an average home’s build time by six weeks and costs by 40%. The bet is structural: the US is millions of homes short and its construction workforce is aging out. One catch — the round values ICON at $1.4B, below its ~$2B 2022 peak.
What happened
ICON raised a $200M Series D (co-led by Baillie Gifford and BlackRock; Tiger Global and Norwest also in); total funding ~$700M.
Funds scale Titan, its multi-story robotic 3D-printing system, plus a new Austin R&D facility.
Its Prime unit holds $370M+ in government contracts and works with NASA on Moon construction.
Why it matters
Robotic construction targets a $16T market gated by labor shortages and a deep housing deficit.
A claimed 40% cost cut and six-week time saving is the kind of hard ROI that moves builders.
Marquee crossover backers (BlackRock, Baillie Gifford) signal construction tech is investable again.
For investors
ICON (private) is the clearest robotic-construction leader, vertically integrated across hardware, software, and materials.
Defense and space contracts add revenue beyond the housing cycle.
Risk: the $1.4B valuation is down from ~$2B in 2022 — capital returned, but at a reset price.
Read more: Pulse 2.0 (October 13, 2026)
NEUROTECHNOLOGY & BCI
CereGate Raises a Series C to Upgrade Brain Implants Patients Already Have
Munich-based CereGate closed an oversubscribed Series C — led by an unnamed US medtech group, with Budapest’s Impact Ventures joining — to advance brain-computer-interface software that runs on Boston Scientific’s existing deep-brain-stimulation implants. Rather than build new hardware, CereGate layers software onto devices already approved and implanted, initially to treat the gait problems that current Parkinson’s therapy handles poorly. The amount wasn’t disclosed, but an oversubscribed round signals appetite for lower-risk neurotech.
What happened
CereGate closed an oversubscribed Series C led by a US medtech group, with Impact Ventures as a first-time backer; amount undisclosed.
Its software runs on Boston Scientific’s deep-brain-stimulation systems, expanding what already-implanted devices can do.
The first target is gait disorders in Parkinson’s, where existing treatments often fall short.
Why it matters
Building on approved, implanted hardware sidesteps neurotech’s biggest risks: surgery and new-device approval.
It opens a software-margin business in a field long dominated by hardware.
Partnering with an incumbent (Boston Scientific) offers a built-in installed base and distribution.
For Investors
CereGate (private, European) is a rare software-first neurotech play with a lower-risk path to market.
Oversubscription points to strong demand for pragmatic BCI models.
Risk: it’s dependent on a partner’s platform, still in clinical trials, and disclosed no round size or valuation.
Read more: Dealroom (October 14, 2026)
ROBOTICS & AUTOMATION
Ultra Raises $50M to Rent Packing Robots to Warehouses
Brooklyn’s Ultra Robotics raised a $50M Series A led by Framework Ventures, 18 months after its founding, to scale OP1 — a stationary, two-armed robot that packs, sorts, and kits e-commerce orders. Ultra doesn’t sell the robot; it leases it as a service, charging an install fee plus a monthly subscription. The robots run AI models from Physical Intelligence (now valued at $5.6B) and have already packed over 500,000 orders across four states.
What happened
Ultra raised a $50M Series A (Framework Ventures-led, Y Combinator joining); total funding $62M.
Its OP1 two-armed robot packs and sorts orders, installs in hours, and runs on a standard outlet.
Ultra leases robots as a service and has packed 500,000+ orders at customer sites.
Why it matters
Robots-as-a-service lowers the adoption barrier for warehouses wary of big capital outlays.
Splitting labor — Ultra owns the robot and data, Physical Intelligence supplies the AI — is an emerging model.
Real order volume (500k+) is rare proof of deployment at the Series A stage.
For Investors
Ultra (private) is a focused bet on e-commerce fulfillment, with early pricing power as customers see results.
Its tie to Physical Intelligence gives it a frontier-model edge without building one.
Risk: RaaS is capital-intensive and low-margin until utilization is high — the raise funds the fleet, not yet the thesis.
Read more: FinSMEs (October 9, 2026)
QUANTUM COMPUTING
Alice & Bob Runs Quantum Error Correction on Off-the-Shelf Nvidia GPUs
French-American quantum firm Alice & Bob demonstrated, for the first time, decoding its “cat qubit” error-correction codes on standard Nvidia GPUs, using Nvidia’s new NVQLink interface to link quantum and classical hardware. Error correction’s unglamorous bottleneck is the classical computer that has to catch quantum mistakes in microseconds; doing that on off-the-shelf GPUs points to a cheaper, more scalable path to fault tolerance. It’s a proof of concept on synthetic data — not yet real-time — but a meaningful step.
What happened
Alice & Bob decoded its LDPC-cat error-correction codes on Nvidia GPUs via Nvidia’s NVQLink interface (with Quantum Machines’ controller).
It’s the first GPU decoding of these codes through NVQLink — a proof of concept on synthetic data, not real-time.
The approach exploits cat qubits’ biased noise, which makes the decoder’s job lighter.
Why it matters
Decoding — catching quantum errors fast enough — is a core barrier to fault tolerance.
Running it on standard Nvidia GPUs suggests a cheaper, more scalable route than bespoke classical hardware.
It deepens the quantum-plus-GPU architecture Nvidia is pushing across the industry.
For investors
Alice & Bob (private, European) is a leading fault-tolerant contender with a differentiated cat-qubit approach.
Leaning on Nvidia’s ecosystem de-risks part of the classical-compute challenge.
Risk: this is a proof of concept, not real-time, and useful fault-tolerant machines remain years out.
Read more: The Quantum Insider (October 13, 2026)
PARTNER SPOTLIGHT
EYWA by R.Evolution × Longevity Investors
EYWA by R.Evolution is a global regenerative real estate brand redefining what it means to live well. In partnership with Longevity Investors, EYWA creates living ecosystems where architecture, technology, and ancient wisdom converge to elevate human health, measurable wellbeing, and long-term prosperity — translating longevity science directly into the built environment. This is where capital aligns with healthspan infrastructure, and a new category of conscious living begins.
Architecture as a carrier of health — buildings designed from the ground up around the biology of the people inside them
Technology as an amplifier of ancient wisdom — biometric data and natural systems integrated at the design level
Wellbeing as a measurable asset — longevity science embedded in every structural and environmental decision
Community as a protective layer — a curated global ecosystem of health-conscious individuals
IP as scalable value — a multi-platform ecosystem for designing human life, built to grow with the science
What signals should be on our radar?
If you’d like to be featured, spotlight a deal, or explore a partnership, just reply to this email and we’ll take it from there.
We’re all ears on how to make Future Investments News truly indispensable for you -tell us what would make this your go-to read on frontier tech and the next decade of investment. If this issue delivered value, please forward it to a colleague or LP.
Disclaimer
Prepared by Future Investments News for general information only; not investment, legal, or tax advice. No offer or solicitation to buy or sell any security or financial instrument. Past trends and transactions are not reliable indicators of future results. Readers should conduct their own due diligence and consult qualified advisers before making decisions.
Stay ahead,
Future Investments News team.
Future Investments News — Signals shaping the next decade of investment.